Navigation Links
Big Pharma already has a generic strategy, but needs new direction


In his February 14, 2005 article, Michael Rosen argues that Big Pharma "will be forced into generic-drug strategy," and suggests that this will be a good thing. But Big Pharma already has a generic drug strategy for traditional pharmaceuticals. This strategy has not been particularly good for anyone,......

Full article >>> nd become subject to generic competition.

Blockbuster drugs have provided valuable therapies ranging from non-sedating antihistamines, cancer treatments, pain relief and, yes, even erectile dysfunction. But the number of conditions that could give rise to a blockbuster drug is limited. Countless medical conditions exist that lack adequate treatment or would benefit from improved treatment......

Full article >>> can and should be done to encourage healthier eating and exercising among the American population. With a healthier population, there will be less need for drugs to treat for conditions such as obesity-induced diabetes. More resources should then be available to develop drugs for other conditions such as cancer and macular degeneration.

The bottom line is that we do not need Big Pharma t......

Full article >>>
'"/>

Source:wistechnology.com By Steven F. Weinstock and Patricia J. Kaeding 03/16/05


Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
4. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
5. Deltanoid Pharmaceuticals begins phase II osteoporosis study
6. The deconstruction of Big Pharma
7. First half of 2006 roundup: Big Pharma trumps biotech
8. Big Pharmas continued hunger and search for new products
9. Leading global Big Pharma companies of 2005
10. Theres more than a bit of mystery, but attracting Big Pharma is good for the state
11. Biotech flourishes in 2005 while Big Pharma is on the decline
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):